Literature DB >> 16005030

NMDA-induced potentiation of mGluR5 is mediated by activation of protein phosphatase 2B/calcineurin.

Sudar Alagarsamy1, Julie Saugstad, Lee Warren, Isabelle M Mansuy, Robert W Gereau, P Jeffrey Conn.   

Abstract

Previous reports have shown that activation of N-methyl-D-aspartate (NMDA) receptors potentiates responses to activation of the group I metabotropic glutamate receptor mGluR5 by reversing PKC-mediated desensitization of this receptor. NMDA-induced reversal of mGluR5 desensitization is dependent on activation of protein phosphatases. However, the specific protein phosphatase involved and the precise mechanism by which NMDA receptor activation reduces mGluR desensitization are not known. We have performed a series of molecular, biochemical, and genetic studies to show that NMDA-induced regulation of mGluR5 is dependent on activation of calcium-dependent protein phosphatase 2B/calcineurin (PP2B/CaN). Furthermore, we report that purified calcineurin directly dephosphorylates the C-terminal tail of mGluR5 at sites that are phosphorylated by PKC. Finally, immunoprecipitation and GST fusion protein pull-down experiments reveal that calcineurin interacts with mGluR5, suggesting that these proteins could be colocalized in a signaling complex. Taken together with previous studies, these data suggest that activation of NMDA receptors leads to activation of calcineurin and that calcineurin modulates mGluR5 function by directly dephosphorylating mGluR5 at PKC sites that are involved in desensitization of this receptor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16005030      PMCID: PMC3799794          DOI: 10.1016/j.neuropharm.2005.05.005

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  43 in total

1.  Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones.

Authors:  A Pisani; P Calabresi; D Centonze; G Bernardi
Journal:  Br J Pharmacol       Date:  1997-03       Impact factor: 8.739

Review 2.  The mechanism of action of cyclosporin A and FK506.

Authors:  S Ho; N Clipstone; L Timmermann; J Northrop; I Graef; D Fiorentino; J Nourse; G R Crabtree
Journal:  Clin Immunol Immunopathol       Date:  1996-09

3.  Activation of group I mGluRs potentiates NMDA responses in rat hippocampal slices.

Authors:  S M Fitzjohn; A J Irving; M J Palmer; J Harvey; D Lodge; G L Collingridge
Journal:  Neurosci Lett       Date:  1996-01-26       Impact factor: 3.046

4.  (RS)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus.

Authors:  A J Doherty; M J Palmer; J M Henley; G L Collingridge; D E Jane
Journal:  Neuropharmacology       Date:  1997-02       Impact factor: 5.250

5.  Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP.

Authors:  Y M Lu; Z Jia; C Janus; J T Henderson; R Gerlai; J M Wojtowicz; J C Roder
Journal:  J Neurosci       Date:  1997-07-01       Impact factor: 6.167

6.  Genetic and pharmacological evidence for a novel, intermediate phase of long-term potentiation suppressed by calcineurin.

Authors:  D G Winder; I M Mansuy; M Osman; T M Moallem; E R Kandel
Journal:  Cell       Date:  1998-01-09       Impact factor: 41.582

7.  Restricted and regulated overexpression reveals calcineurin as a key component in the transition from short-term to long-term memory.

Authors:  I M Mansuy; M Mayford; B Jacob; E R Kandel; M E Bach
Journal:  Cell       Date:  1998-01-09       Impact factor: 41.582

8.  Role of protein kinase C phosphorylation in rapid desensitization of metabotropic glutamate receptor 5.

Authors:  R W Gereau; S F Heinemann
Journal:  Neuron       Date:  1998-01       Impact factor: 17.173

9.  4-Methylhomoibotenic acid activates a novel metabotropic glutamate receptor coupled to phosphoinositide hydrolysis.

Authors:  D S Chung; S F Traynelis; T J Murphy; P J Conn
Journal:  J Pharmacol Exp Ther       Date:  1997-11       Impact factor: 4.030

10.  Phosphorylation and calmodulin binding of the metabotropic glutamate receptor subtype 5 (mGluR5) are antagonistic in vitro.

Authors:  R Minakami; N Jinnai; H Sugiyama
Journal:  J Biol Chem       Date:  1997-08-08       Impact factor: 5.157

View more
  34 in total

1.  Defining protein kinase/phosphatase isoenzymic regulation of mGlu₅ receptor-stimulated phospholipase C and Ca²⁺ responses in astrocytes.

Authors:  S J Bradley; R A J Challiss
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 2.  Location-dependent signaling of the group 1 metabotropic glutamate receptor mGlu5.

Authors:  Yuh-Jiin I Jong; Ismail Sergin; Carolyn A Purgert; Karen L O'Malley
Journal:  Mol Pharmacol       Date:  2014-10-17       Impact factor: 4.436

3.  Potentiation of mGlu5 receptors with the novel enhancer, VU0360172, reduces spontaneous absence seizures in WAG/Rij rats.

Authors:  V D'Amore; I Santolini; C M van Rijn; F Biagioni; G Molinaro; A Prete; P J Conn; C W Lindsley; Y Zhou; P N Vinson; A L Rodriguez; C K Jones; S R Stauffer; F Nicoletti; G van Luijtelaar; R T Ngomba
Journal:  Neuropharmacology       Date:  2012-06-15       Impact factor: 5.250

Review 4.  What can we get from 'barrels': the rodent barrel cortex as a model for studying the establishment of neural circuits.

Authors:  Chia-Shan Wu; Carlos J Ballester Rosado; Hui-Chen Lu
Journal:  Eur J Neurosci       Date:  2011-11       Impact factor: 3.386

5.  G protein-coupled receptor kinase 2 and group I metabotropic glutamate receptors mediate inflammation-induced sensitization to excitotoxic neurodegeneration.

Authors:  Vincent Degos; Stéphane Peineau; Cora Nijboer; Angela M Kaindl; Stéphanie Sigaut; Géraldine Favrais; Frank Plaisant; Natacha Teissier; Elodie Gouadon; Alain Lombet; Elie Saliba; Graham L Collingridge; Mervyn Maze; Ferdinando Nicoletti; Cobi Heijnen; Jean Mantz; Annemieke Kavelaars; Pierre Gressens
Journal:  Ann Neurol       Date:  2013-03-14       Impact factor: 10.422

Review 6.  Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia.

Authors:  P Jeffrey Conn; Craig W Lindsley; Carrie K Jones
Journal:  Trends Pharmacol Sci       Date:  2008-12-06       Impact factor: 14.819

7.  Calcineurin inhibitor protein (CAIN) attenuates Group I metabotropic glutamate receptor endocytosis and signaling.

Authors:  Lucimar T Ferreira; Lianne B Dale; Fabiola M Ribeiro; Andy V Babwah; Macarena Pampillo; Stephen S G Ferguson
Journal:  J Biol Chem       Date:  2009-08-28       Impact factor: 5.157

Review 8.  Emerging approaches for treatment of schizophrenia: modulation of glutamatergic signaling.

Authors:  Meredith J Noetzel; Carrie K Jones; P Jeffrey Conn
Journal:  Discov Med       Date:  2012-11       Impact factor: 2.970

9.  Functional interactions between presynaptic NMDA receptors and metabotropic glutamate receptors co-expressed on rat and human noradrenergic terminals.

Authors:  E Luccini; V Musante; E Neri; M Brambilla Bas; P Severi; M Raiteri; A Pittaluga
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

Review 10.  Group I metabotropic glutamate receptors: a role in neurodevelopmental disorders?

Authors:  Maria Vincenza Catania; Simona D'Antoni; Carmela Maria Bonaccorso; Eleonora Aronica; Mark F Bear; Ferdinando Nicoletti
Journal:  Mol Neurobiol       Date:  2007-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.